B.C. medical isotope ‘trailblazer’ ARTMS fetches US$82M in Telix acquisition

  • 📰 BurnabyNOW_News
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 77%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

Deal includes US$15M upfront cash, US$42.5M in shares and potential US$24.5M bonus

A West Coast life sciences firm known for whipping up medical isotopes has whipped up a sizeable asking price for its sale.

Its goal is to address a global shortage of medical isotopes, which are used in diagnosing cancer and cardiac conditions. The global supply of medical isotopes previously relied on production from a nuclear reactor in Chalk River, Ont., which produced a large quantity of a parent isotope that decayed over time to form the medical isotope.That opened the door for ARTMS to use research from Triumf for commercial ventures.

Telix CEO Christian Behrenbruch described ARTMS as a “trailblazer” in the field of next generation cyclotron-based isotope production systens.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 14. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

B.C. medical isotope ‘trailblazer’ ARTMS fetches US$82M in Telix acquisitionDeal includes US$15M upfront cash, US$42.5M in shares and potential US$24.5M bonus
Bron: PGCitizen - 🏆 65. / 51 Lees verder »